Skip to main content
Clinical Trials/NL-OMON39561
NL-OMON39561
Completed
Phase 3

Early recognition and optimal treatment of delirium in patients with advanced cancer - RCT Delirium in cancer patients

Vrije Universiteit Medisch Centrum0 sites200 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
200
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \* Patient has been diagnosed with advanced cancer;
  • \* Age \* 18;
  • \* Patient or his / her significant other speaks Dutch fluently.

Exclusion Criteria

  • \* Delirium is due to alcohol withdrawal;
  • \* Patient has been diagnosed with glaucoma, Parkinson\*s disease or dementia;
  • \* Patient is being treated with other neuroleptic medication or lithium (except for low dose neuroleptics used in the treatment of neuropathic pain);
  • \* Patient has another psychiatric disorder that is considered (by investigator) to interfere with assessment of delirium;
  • \* Patient had a QTc\-interval of \> 500 msec on ECG made on admission;
  • \* Patient has a history of neuroleptic malignant syndrome;
  • \* Patient has a history of convulsions.

Outcomes

Primary Outcomes

Not specified

Similar Trials